|
- BrightEdge | Cancer Social Impact Investing | Cancer Impact Fund
BrightEdge is the Philanthropic Impact Fund of the American Cancer Society aimed at investing in companies that accelerate the ACS mission to fight cancer
- American Cancer Society BrightEdge Annual Report Reveals Impact of $43 . . .
BrightEdge is the American Cancer Society's donor-funded innovation and impact investment arm that invests in for-profit companies developing therapeutics, diagnostics, medical devices, and technologies to eradicate cancer
- Amplifying Innovation Driving Impact - American Cancer Society
Establish a new standard for oncology investments, aligned with current market practices Enhance investment rigor through scientific expertise Strengthen BrightEdge’s leadership, and foster collaboration in the field
- Press Releases - American Cancer Society MediaRoom
BrightEdge is the American Cancer Society's donor-funded innovation and impact investment arm that invests in for-profit companies developing therapeutics, diagnostics, medical devices, and technologies to support ACS’s mission to end cancer as we know it, for everyone
- THE FIGHT AGAINST CANCER
and n impact leaders nd impact investing arm To learn more about BrightEdge and read the 2022 Annual Report, e know it, for everyone To learn more ab
- Press Releases - American Cancer Society MediaRoom
BrightEdge makes equity investments in private companies to translate cancer research into commercially accessible solutions, while generating financial returns to help sustain ongoing cancer research and patient services
- American Cancer Society
American Cancer Society
- BrightEdge Announces Second Investment in Freenome, Technology Firm . . .
BrightEdge is the American Cancer Society’s donor-funded, philanthropic venture capital fund The fund invests in for-profit companies developing novel cancer-focused treatments
|
|
|